Objective To verify glomerular PLA2R antigen and serum PLA2R antibody expression in
membranous nephropathy as well as to explore glomerular PLA2R efficacy in evaluating the …

Objective To compare the positive rate of anti-PLA2R antibodies in patients with primary
membranous nephropathy (PMN), secondary membranous nephropathy (SMN), and non …

Objective To detect the expression of renal M-type phospholipase A2 receptor (PLA2R) in
patients with idiopathic membranous nephropathy (IMN), and to explore the relationship …

Anti-PLA2R antibodies (Ab) are a diagnostic and prognostic biomarker in primary
membranous nephropathy (PMN). We assessed the relationship between the levels of anti …

Abstract Background Phospholipase A2 receptor (PLA2R)-associated membranous
nephropathy (MN) was manifested as seropositive for PLA2R antibodies (SAb) and/or …

Objectives This study aimed to establish time-resolved fluorescence immunoassays to
quantitatively detect the autoantibodies targeting different epitopes of M-type phospholipase …

Objective To investigate the prevalence of PLA2R1 in renal biopsy specimens of patients
with idiopathic membranous nephropathy (IMN) and explore the relationship between …

Background The diagnostic performance of PLA2R and IgG subclass staining of kidney
biopsies relative to anti-PLA2R seropositivity in the differentiation of primary and secondary …

Background: M-type phospholipase A 2 receptor (PLA 2 R) has been identified as the major
target antigen in idiopathic membranous nephropathy (IMN). However, the role of …

Background Since the emergence of the anti-PLA2R antibody (PLA2R-Ab) test, nephrology
practice has not changed dramatically, with most nephrologists still relying on a kidney …